Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications
June 20, 2017 16:01 ET
|
Trevena Inc.
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...
Elsevier Recognizes Alzheimer's - Brain Awareness Month with New Book, "A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease"
June 06, 2017 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - June 06, 2017) - Elsevier, the information analytics company specializing in science and health, today announced A Roadmap for Curing Cancer, Alzheimer's, and...
Rheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration Budget
May 23, 2017 16:51 ET
|
American College of Rheumatology
Atlanta, May 23, 2017 (GLOBE NEWSWIRE) -- ATLANTA – The American College of Rheumatology (ACR) today expressed opposition to the Trump Administration’s proposed budget cuts to federal programs and...
Alzheimer’s Foundation of America’s Statement on the Trump Administration’s Proposed 2018 Budget
May 23, 2017 15:40 ET
|
Alzheimer's Foundation of America
NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- Today, the Trump Administration released its proposed federal budget for fiscal year 2018, which makes deep cuts in funding for the National Institutes of...
Amydis Diagnostics Awarded NIH Grant to Further Investigate Innovative Technology for Early Detection of Alzheimer’s Disease
March 20, 2017 07:07 ET
|
Amydis Diagnostics, Inc.
SAN DIEGO, March 20, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Alzheimer’s Foundation of America Calls on the Trump Administration to Increase Alzheimer’s Research Spending
February 01, 2017 12:31 ET
|
Alzheimer's Foundation of America
NEW YORK, Feb. 01, 2017 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA)—a national non-profit organization, that unites more than 2,600 member organizations nationwide, in the goal...
O2 RegenTech Receives $600,000 to Develop Oxygenating Wound Treatments
January 26, 2017 07:05 ET
|
O2 RegenTech
AKRON, Ohio, Jan. 26, 2017 (GLOBE NEWSWIRE) -- O2 RegenTech, a medical technology company focused on wound care solutions, has been awarded a $225,000 National Science Foundation (NSF) Small...
ConverGene Announces a License Agreement With the National Center for Advancing Translational Sciences
December 13, 2016 16:14 ET
|
ConverGene LLC
CAMBRIDGE, Md., Dec. 13, 2016 (GLOBE NEWSWIRE) -- ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the...
Hemispherx Biopharma Reviews Ampligen® Data With National Institute of Neurological Disorders and Stroke (NINDS)
March 10, 2016 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 10, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced that the strong commitment by the National Institutes of Health (NIH)...
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance a Stable, Non-Aqueous Diazepam, Subcutaneous Injection for Treatment of Acute Repetitive Seizures in Patients with Epilepsy
October 01, 2015 10:15 ET
|
Xeris Pharmaceuticals, Inc.
Austin, Texas, Oct. 01, 2015 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), an Austin-based, emerging biopharmaceutical company developing patient-friendly injectable treatments, was...